Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlgalR NutraPharms is a biotechnology company based in India that focuses on the sustainable production of Omega-3 fatty acids through microalgal fermentation. The company specializes in docosahexaenoic acid (DHA) derived from Schizochytrium species, offering a vegan and eco-friendly alternative to traditional fish oil. Their core business involves the manufacturing of high-quality algal DHA oil and powder for use in the pharmaceutical, nutraceutical, and food industries. AlgalR's proprietary technology platform enables large-scale cultivation and extraction processes that ensure high purity and stability of their products. The company serves a global market, providing essential nutrients for infant nutrition, prenatal care, and general health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlgalR NutraPharms.